179 related articles for article (PubMed ID: 25192260)
1. Exploring the scaffold universe of kinase inhibitors.
Hu Y; Bajorath J
J Med Chem; 2015 Jan; 58(1):315-32. PubMed ID: 25192260
[TBL] [Abstract][Full Text] [Related]
2. Mapping Biological Activities to Different Types of Molecular Scaffolds: Exemplary Application to Protein Kinase Inhibitors.
Dimova D; Bajorath J
Methods Mol Biol; 2018; 1825():327-337. PubMed ID: 30334211
[TBL] [Abstract][Full Text] [Related]
3. Structural diversity and potency range distribution of scaffolds from compounds active against current pharmaceutical targets.
Kayastha S; Dimova D; Stumpfe D; Bajorath J
Future Med Chem; 2015; 7(2):111-22. PubMed ID: 25686001
[TBL] [Abstract][Full Text] [Related]
4. Target family-directed exploration of scaffolds with different SAR profiles.
Hu Y; Bajorath J
J Chem Inf Model; 2011 Dec; 51(12):3138-48. PubMed ID: 22091691
[TBL] [Abstract][Full Text] [Related]
5. Structural and Activity Profile Relationships Between Drug Scaffolds.
Hu Y; Bajorath J
AAPS J; 2015 May; 17(3):609-19. PubMed ID: 25697829
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of three-dimensional activity cliffs formed by kinase inhibitors with different binding modes and cliff mapping of structural analogues.
Furtmann N; Hu Y; Bajorath J
J Med Chem; 2015 Jan; 58(1):252-64. PubMed ID: 25054653
[TBL] [Abstract][Full Text] [Related]
7. Activity profile relationships between structurally similar promiscuous compounds.
Hu Y; Bajorath J
Eur J Med Chem; 2013 Nov; 69():393-8. PubMed ID: 24077530
[TBL] [Abstract][Full Text] [Related]
8. Advancing the kinase field: new targets and second generation inhibitors.
Laufer S; Bajorath J
J Med Chem; 2015 Jan; 58(1):1. PubMed ID: 25490234
[No Abstract] [Full Text] [Related]
9. Mapping of inhibitors and activity data to the human kinome and exploring promiscuity from a ligand and target perspective.
Hu Y; Kunimoto R; Bajorath J
Chem Biol Drug Des; 2017 Jun; 89(6):834-845. PubMed ID: 27933727
[TBL] [Abstract][Full Text] [Related]
10. Systematic assessment of scaffold hopping versus activity cliff formation across bioactive compound classes following a molecular hierarchy.
Stumpfe D; Dimova D; Bajorath J
Bioorg Med Chem; 2015 Jul; 23(13):3183-91. PubMed ID: 25982076
[TBL] [Abstract][Full Text] [Related]
11. Inhibitor scaffold for the histone lysine demethylase KDM4C (JMJD2C).
Leurs U; Clausen RP; Kristensen JL; Lohse B
Bioorg Med Chem Lett; 2012 Sep; 22(18):5811-3. PubMed ID: 22917519
[TBL] [Abstract][Full Text] [Related]
12. Toward an efficient approach to identify molecular scaffolds possessing selective or promiscuous compounds.
Yongye AB; Medina-Franco JL
Chem Biol Drug Des; 2013 Oct; 82(4):367-75. PubMed ID: 23659738
[TBL] [Abstract][Full Text] [Related]
13. Focused library with a core structure extracted from natural products and modified: application to phosphatase inhibitors and several biochemical findings.
Hirai G; Sodeoka M
Acc Chem Res; 2015 May; 48(5):1464-73. PubMed ID: 25894598
[TBL] [Abstract][Full Text] [Related]
14. Development and experimental validation of a docking strategy for the generation of kinase-targeted libraries.
Gozalbes R; Simon L; Froloff N; Sartori E; Monteils C; Baudelle R
J Med Chem; 2008 Jun; 51(11):3124-32. PubMed ID: 18479119
[TBL] [Abstract][Full Text] [Related]
15. Identification of Bioactive Scaffolds Based on QSAR Models.
Nakagawa T; Miyao T; Funatsu K
Mol Inform; 2018 Jan; 37(1-2):. PubMed ID: 29135084
[TBL] [Abstract][Full Text] [Related]
16. Many drugs contain unique scaffolds with varying structural relationships to scaffolds of currently available bioactive compounds.
Hu Y; Bajorath J
Eur J Med Chem; 2014 Apr; 76():427-34. PubMed ID: 24602788
[TBL] [Abstract][Full Text] [Related]
17. Matched molecular pair analysis of small molecule microarray data identifies promiscuity cliffs and reveals molecular origins of extreme compound promiscuity.
Dimova D; Hu Y; Bajorath J
J Med Chem; 2012 Nov; 55(22):10220-8. PubMed ID: 23050678
[TBL] [Abstract][Full Text] [Related]
18. Predicting kinase selectivity profiles using Free-Wilson QSAR analysis.
Sciabola S; Stanton RV; Wittkopp S; Wildman S; Moshinsky D; Potluri S; Xi H
J Chem Inf Model; 2008 Sep; 48(9):1851-67. PubMed ID: 18717582
[TBL] [Abstract][Full Text] [Related]
19. Systematic computational identification of promiscuity cliff pathways formed by inhibitors of the human kinome.
Miljković F; Vogt M; Bajorath J
J Comput Aided Mol Des; 2019 Jun; 33(6):559-572. PubMed ID: 30915709
[TBL] [Abstract][Full Text] [Related]
20. Systematic assessment of coordinated activity cliffs formed by kinase inhibitors and detailed characterization of activity cliff clusters and associated SAR information.
Dimova D; Stumpfe D; Bajorath J
Eur J Med Chem; 2015 Jan; 90():414-27. PubMed ID: 25461890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
